Bridgeway Capital Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-114,900
| Closed | -$564K | – | 1356 |
|
|
2021
Q3 | $564K | Sell |
114,900
-150,000
| -57% | -$736K | 0.01% | 999 |
|
|
2021
Q2 | $1.4M | Buy |
264,900
+85,000
| +47% | +$449K | 0.03% | 742 |
|
|
2021
Q1 | $864K | Buy |
179,900
+50,000
| +38% | +$240K | 0.02% | 914 |
|
|
2020
Q4 | $562K | Buy |
129,900
+4,900
| +4% | +$21.2K | 0.01% | 903 |
|
|
2020
Q3 | $515K | Sell |
125,000
-60,000
| -32% | -$247K | 0.01% | 876 |
|
|
2020
Q2 | $474K | Buy |
185,000
+90,000
| +95% | +$231K | 0.01% | 872 |
|
|
2020
Q1 | $275K | Sell |
95,000
-20,000
| -17% | -$57.9K | 0.01% | 959 |
|
|
2019
Q4 | $436K | Hold |
115,000
| – | – | 0.01% | 1038 |
|
|
2019
Q3 | $588K | Hold |
115,000
| – | – | 0.01% | 884 |
|
|
2019
Q2 | $713K | Sell |
115,000
-30,000
| -21% | -$186K | 0.01% | 859 |
|
|
2019
Q1 | $1.03M | Buy |
+145,000
| New | +$1.03M | 0.01% | 756 |
|